Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Germany | Publication | September 2021
Dear reader,
The Art of Dispute comprises, amongst other things, the ability to assess a situation correctly and act proactively and with the right strategy. Our newsletter provides practical advice and a concise analysis of key case law and recent developments in dispute resolution.
In this issue, we cover the latest developments in litigation funding and class actions, patent infringement and money laundering offences. We also look at the legal changes in warning letters and how the German courts have been viewing arbitration clauses.
Moreover, we present to you our award-winning legal tech offering NRF Transform and explain the Norton Rose Fulbright Litigation Manager.
We endeavor to offer you specific legal advice and to represent and protect your interests in the best possible way. We look forward to exchanging ideas with you and are happy to answer any questions that you may have. Finally, we take you through all of the services and products we have to offer to best support you in answering your concerns. For further support on your queries please contact any member of our team, details at the end of our brochure.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023